An early sign of
ABCA4-disease that is detectable noninvasively is the abnormality of AF intensity.
14 16 28 43 44 Illustrating an early
ABCA4-disease stage is Patient 42 (P42, see Ref.
16 ), a 23-year-old man with clinically diagnosed
11 STGD phenotype I and a molecularly diagnosed G1961E mutation in the
ABCA4 gene. He had best corrected visual acuities of 20/40 and 20/100 in the right and left eyes, respectively. Both eyes showed a full extent of Goldmann kinetic visual field with the V-4e and I-4e test targets but a relative central scotoma with the I-4e target. AF imaging of his left eye showed a dramatic increase of intensity across the central retina (
Fig. 1B , displayed as equivalent right eye). The abnormal intensity was spatially homogeneous throughout most of the central retina except near the fovea where there were small regions of AF intensity loss with the resultant local spatial heterogeneity. Notable was a region of normal-appearing AF intensity encircling the ONH. A more advanced disease stage of
ABCA4-RD is illustrated by P46, a 48-year-old woman with clinically diagnosed STGD phenotype II and a molecularly diagnosed R2030Q mutation in the
ABCA4 gene. She had best corrected visual acuities of 20/200 and 20/20 in the right and left eyes, respectively, and full peripheral extent of kinetic fields. Centrally, there was a small island of retained function (with the V-4e target) surrounded by an absolute scotoma and a larger relative scotoma. AF imaging of her right eye showed intensities distributed mostly within the normal range, but there was abnormal spatial heterogeneity
(Fig. 1C)with a speckled pattern. This pattern has been hypothesized to correspond to microscopic variation in the rates of abnormal lipofuscin accumulation, or to the patchy loss of a subset of RPE cells, or to the reduction of OS shedding as the overlying retina degenerates.
16 Two regions of presumed RPE atrophy were also apparent as patches of low intensity in the superior and inferior parafovea. Of note, there was a spatially homogenous circular region of normal-appearing intensity at the parapapillary retina. A severe disease stage of
ABCA4-RD is represented by P37, a 41-year-old man with clinically diagnosed STGD phenotype II and a molecularly diagnosed IVS40+5G→A mutation in the
ABCA4 gene. He had best corrected visual acuities of 20/400 and 20/200 in right and left eyes, respectively. Kinetic perimetry with the V-4e target showed superior field limitation but was otherwise full in peripheral extent; an absolute central scotoma was present in each eye. There was no detection of the I-4e target. AF imaging of his right eye showed extensive regions of presumed RPE atrophy across the posterior pole, with small intervening regions of detectable AF probably originating from retained RPE. A normal-appearing parapapillary ring was visible
(Fig. 1D) .